LKFT Earnings Date: Nov 11, 2026 (Estimated) — Lakefront Biotherapeutics N.V.

NASDAQ

Updated Oct 30, 2026

Price $32.50

Market Cap $2.1B

P/E 3.6

52W Range $25.68 – $36.24

Next Earnings Nov 11, 2026 · After close (est.)

When is LKFT's next earnings date?

Lakefront Biotherapeutics N.V. (LKFT) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.83 on revenue of $7.5M.

How did LKFT do in its last earnings report?

In its most recent report on Aug 10, 2026 (Q2 2026), Lakefront Biotherapeutics N.V. posted EPS of $0.29 versus the -$0.82 estimate, a beat of 102.1%. Revenue was $21.6M against a $6.2M estimate. The stock's 1-day post-earnings move was +6.8%.

How much does LKFT stock move after earnings?

LKFT beat EPS estimates in 2 of its last 2 reported quarters. Over the last 2 reports the stock moved an average of 5.3% (up or down) in the day after earnings.

About Lakefront Biotherapeutics N.V.

Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.